AC
AI Cancer Cure

Evidence Atlas, updating nightly

Explore

Cancer trials

Adrenal cancers trials

Recruiting and active trials mapped to Adrenal cancers. Adjust filters as needed.

3 trialsSorted by top rated
RECRUITINGRating 81

Phase

Not listed

Sponsor

Assistance Publique - Hôpitaux de Paris

Last update

2024-01-09

Patient usefulness rating

81/100

Relevance score

44/100

Conditions

Cancer, Adrenal

Interventions

Not listed

Eligibility

Inclusion Criteria * Patients 18 years of age and older * Patients with an adrenal tumor who will be operated of a potentially malignant adrenocortical carcinoma (ACC) or pheochromocytoma or paraganglioma (MPP)…

Locations

1 sites

AI-generated summary

Summary not available yet.

This summary may be inaccurate. Verify against ClinicalTrials.gov.

Primary source facts: ClinicalTrials.gov metadata.

UNKNOWNRating 59

Phase

Not listed

Sponsor

SpeciCare

Last update

2020-12-04

Patient usefulness rating

59/100

Relevance score

36/100

Conditions

Cancer, All Types, Cancer of Liver, Cancer of Stomach, Cancer of Head and Neck +41

Interventions

Not listed

Eligibility

Inclusion Criteria: \- All patients diagnosed with cancer and all patients at risk of cancer Exclusion Criteria: -Patients who decline definitive therapies Patients with comorbidities that prevent definitive therapies Patients on hospice

Locations

1 sites

AI-generated summary

The PIONEER Initiative is testing a system to provide functional precision medicine testing on a patient’s tumor tissue, which can include organoid drug screening and genomic profiling to help guide therapy decisions. It is for all cancer patients and for people at risk of cancer, at any medical facility, with tumor tissue collected at biopsy or surgery and stored for current or future testing. The study aims to learn whether researchers can return the test results to the patient and their clinicians, and whether this information provides added benefit over standard care. Exclusions include patients who decline definitive therapies, those with comorbidities that prevent definitive therapies, and patients on hospice.

This summary may be inaccurate. Verify against ClinicalTrials.gov.

Primary source facts: ClinicalTrials.gov metadata.

COMPLETEDRating 51

Phase

Not listed

Sponsor

Taproot Health

Last update

2024-12-18

Patient usefulness rating

51/100

Relevance score

32/100

Conditions

Adenocarcinoma, Adenocystic Carcinoma, Anal Cancer, Appendix Cancer +72

Interventions

Not listed

Eligibility

Inclusion Criteria: * Patient or representative provides written informed consent * Patient is diagnosed with advanced malignancy * Patient is willing to be treated for this malignancy according to a plan determine…

Locations

2 sites

AI-generated summary

The Registry of Oncology Outcomes Associated with Testing and Treatment is being studied. Conditions: Adenocarcinoma, Adenocystic Carcinoma, Anal Cancer +73 • Eligibility: Inclusion Criteria: * Patient or representative provides written informed consent * Patient is diagnosed with advanced malignancy * Patient is willing to be treated for this malignancy according…. Goal: This study is to collect and validate regulatory-grade real-world data (RWD) in oncology using the novel, Master Observational Trial construct. This data can be then used in real-world evidence (RWE) generation. Phase/Status/Sponsor: Unknown phase; COMPLETED; Taproot Health.

This summary may be inaccurate. Verify against ClinicalTrials.gov.

Primary source facts: ClinicalTrials.gov metadata.